BREVIBLOC Side Effects

6901684-6 | Agitation, Delirium, Hyperhidrosis, Paranoia
on Jul 23, 2010 Female patient from UNITED STATES , 60 years of age, weighting 169.8 lb, was diagnosed with blood pressure management and was treated with Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, delirium, hyperhidrosis, paranoia. Brevibloc dosage: . During the same period patient was treated with DIHYDRALAZINE (View Dihydralazine Review and Dihydralazine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TRANDATE (View Trandate Review and Trandate Label ). Patient was hospitalized.

6901052-7 | Agitation, Delirium, Hyperhidrosis, Paranoia
Patient was taking Brevibloc (View Usage). Patient had the following side effects: agitation, delirium, hyperhidrosis, paranoia on Jul 23, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 178.6 lb, was diagnosed with blood pressure management and. Brevibloc dosage: . During the same period patient was treated with HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

6863097-5 | Multi-organ Failure
Adverse event was reported on Jul 13, 2010 by a Male patient taking Brevibloc (View Usage) (Dosage: ) was diagnosed with off label use and. Location: GERMANY , weighting 11.02 lb, After Brevibloc was administered, patient had the following side effects: multi-organ failure.

6170700-4 | Blood Pressure Decreased
on Apr 21, 2009 Female patient from CANADA , 70 years of age, weighting 108.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased. Brevibloc dosage: . During the same period patient was treated with AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ).


5517727-0 | Anaphylactic Reaction, Bradycardia, Cardiac Arrest, Convulsion, Cranial Nerve Disorder, Delayed Recovery From Anaesthesia, Mental Impairment, Shock, Ventricular Fibrillation
on Nov 07, 2007 Male patient from UNITED STATES , 27 years of age, was diagnosed with tachycardia, maintenance of anaesthesia, endotracheal intubation and was treated with Brevibloc (View Usage). Patient had the following side effects: anaphylactic reaction, bradycardia, cardiac arrest (What is cardiac arrest?), convulsion, cranial nerve disorder, delayed recovery from anaesthesia, mental impairment, shock, ventricular fibrillation. Brevibloc dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), LIDOCAINE AND EPINEPHRINE (View Lidocaine And Epinephrine Review and Lidocaine And Epinephrine Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VEEN F (View Veen-f Review and Veen-f Label ).

5517720-8 | Anaphylactic Reaction, Bradycardia, Cardiac Arrest, Convulsion, Cranial Nerve Disorder, Delayed Recovery From Anaesthesia, Mental Impairment, Shock, Ventricular Fibrillation
Patient was taking Brevibloc (View Usage). After Brevibloc was administered, patient had the following side effects: anaphylactic reaction, bradycardia, cardiac arrest (What is cardiac arrest?), convulsion, cranial nerve disorder, delayed recovery from anaesthesia, mental impairment, shock, ventricular fibrillation on Nov 07, 2007 from UNITED STATES Additional patient health information: Male patient , 27 years of age, was diagnosed with tachycardia, maintenance of anaesthesia, endotracheal intubation and. Brevibloc dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), LIDOCAINE AND EPINEPHRINE (View Lidocaine And Epinephrine Review and Lidocaine And Epinephrine Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VEEN F (View Veen-f Review and Veen-f Label ).

5517705-1 | Anaphylactic Reaction, Bradycardia, Cardiac Arrest, Convulsion, Cranial Nerve Disorder, Delayed Recovery From Anaesthesia, Mental Impairment, Shock, Ventricular Fibrillation
Adverse event was reported on Nov 07, 2007 by a Male patient taking Brevibloc (View Usage) (Dosage: ) was diagnosed with tachycardia, maintenance of anaesthesia, endotracheal intubation and. Location: UNITED STATES , 27 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, bradycardia, cardiac arrest (What is cardiac arrest?), convulsion, cranial nerve disorder, delayed recovery from anaesthesia, mental impairment, shock, ventricular fibrillation. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), LIDOCAINE AND EPINEPHRINE (View Lidocaine And Epinephrine Review and Lidocaine And Epinephrine Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VEEN F (View Veen-f Review and Veen-f Label ).

5508623-3 | Bradycardia, Cranial Nerve Disorder, Shock
on Oct 31, 2007 Male patient from JAPAN , 27 years of age, was diagnosed with endotracheal intubation, maintenance of anaesthesia, fluid replacement and was treated with Brevibloc (View Usage). Patient had the following side effects: bradycardia, cranial nerve disorder, shock. Brevibloc dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), MUSCULAX (View Musculax Review and Musculax Label ), XYLOCAINE W/ EPINEPHRINE (View Xylocaine W/ Epinephrine Review and Xylocaine W/ Epinephrine Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VEEN F (View Veen-f Review and Veen-f Label ).

5500745-6 | Bradycardia, Hypoxic Encephalopathy, Mental Impairment, Shock
on Oct 23, 2007 Male patient from UNITED STATES , 30 years of age, was treated with Brevibloc (View Usage). After Brevibloc was administered, patient had the following side effects: bradycardia, hypoxic encephalopathy, mental impairment, shock. Brevibloc dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

5499165-2 | Bradycardia, Hypoxic Encephalopathy, Shock
Patient was taking Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, hypoxic encephalopathy, shock on Oct 12, 2007 from JAPAN Additional patient health information: Male patient , 30 years of age, . Brevibloc dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

5385645-7 | Bradycardia, Cardiac Arrest
Adverse event was reported on Jul 05, 2007 by a Male patient taking Brevibloc (View Usage) (Dosage: ) was diagnosed with blood pressure increased, neuromuscular blockade reversal, atrial fibrillation (What is atrial fibrillation?), anaesthesia and. Location: JAPAN , 60 years of age, Patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?). During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

5381771-7 | Bradycardia, Cardiac Arrest
on Jul 05, 2007 Male patient from JAPAN , 60 years of age, weighting 145.5 lb, was diagnosed with tachycardia, blood pressure increased, neuromuscular blockade reversal, atrial fibrillation (What is atrial fibrillation?) and was treated with Brevibloc (View Usage). After Brevibloc was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?). Brevibloc dosage: . During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FENTANEST (View Fentanest Review and Fentanest Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ).

5377091-7 | Atrial Fibrillation, Bradycardia, Cardiac Arrest, Depressed Level Of Consciousness
on Jun 22, 2007 Male patient from JAPAN , 60 years of age, was diagnosed with blood pressure increased, neuromuscular blockade reversal, atrial fibrillation (What is atrial fibrillation?), anaesthesia and was treated with Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, cardiac arrest (What is cardiac arrest?), depressed level of consciousness. Brevibloc dosage: . During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

5377090-5 | Bradycardia, Cardiac Arrest
Patient was taking Brevibloc (View Usage). Patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?) on Jun 22, 2007 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with blood pressure increased, neuromuscular blockade reversal, atrial fibrillation (What is atrial fibrillation?), anaesthesia and. Brevibloc dosage: . During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

5374539-9 | Bradycardia, Cardiac Arrest
Adverse event was reported on Jun 22, 2007 by a Male patient taking Brevibloc (View Usage) (Dosage: ) was diagnosed with tachycardia, blood pressure increased, neuromuscular blockade reversal, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , 60 years of age, weighting 145.5 lb, After Brevibloc was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?). During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FENTANEST (View Fentanest Review and Fentanest Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ).

5352941-9 | Cardiac Arrest
on Jun 01, 2007 Male patient from JAPAN , 60 years of age, was diagnosed with blood pressure increased and was treated with Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Brevibloc dosage: . During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN (View Losartan Review and Losartan Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ).

5352939-0 | Cardiac Arrest
on Jun 01, 2007 Male patient from JAPAN , 60 years of age, was diagnosed with blood pressure increased and was treated with Brevibloc (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Brevibloc dosage: . During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN (View Losartan Review and Losartan Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ).

5350589-3 | Cardiac Arrest
Patient was taking Brevibloc (View Usage). After Brevibloc was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Jun 01, 2007 from JAPAN Additional patient health information: Male patient , 60 years of age, weighting 145.5 lb, was diagnosed with tachycardia, blood pressure increased and. Brevibloc dosage: . During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), ACARBOSE (View Acarbose Review and Acarbose Label ).

5327746-5 | Necrosis, Phlebitis
Adverse event was reported on Sep 11, 2006 by a Female patient taking Brevibloc (View Usage) (Dosage: ) was diagnosed with blood pressure increased and. Location: UNITED STATES , 36 years of age, Patient experienced the following unwanted or unexpected effects: necrosis, phlebitis.

5308742-0 | Lip Oedema, Oedema Mouth
on Apr 16, 2007 Female patient from FRANCE , 55 years of age, was diagnosed with echocardiogram and was treated with Brevibloc (View Usage). Patient had the following side effects: lip oedema, oedema mouth. Brevibloc dosage: . During the same period patient was treated with DOBUTAMINE (View Dobutamine Review and Dobutamine Label ), ATROPINE (View Atropine Review and Atropine Label ). Patient was hospitalized.

5168866-8 | Extravasation, Infusion Site Erythema, Infusion Site Swelling, Skin Necrosis
on Dec 06, 2006 Female patient from UNITED STATES , 78 years of age, weighting 172.0 lb, was treated with Brevibloc (View Usage). After Brevibloc was administered, patient had the following side effects: extravasation, infusion site erythema, infusion site swelling, skin necrosis. Brevibloc dosage: Titrate Iv Drip. Patient was hospitalized.

5100632-1 | Arteriospasm Coronary, Bradycardia, Hypotension, Ventricular Extrasystoles
Patient was taking Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: arteriospasm coronary, bradycardia, hypotension, ventricular extrasystoles on Aug 25, 2006 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 130.0 lb, was diagnosed with post procedural complication, tachycardia and. Brevibloc dosage: 20 Mg; Once; Iv. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ).

5046177-9 | Blood Pressure Decreased, Cerebral Infarction, Disturbance In Attention, Heart Rate Decreased, Iatrogenic Injury, Procedural Complication, Vascular Injury
Adverse event was reported on Jun 07, 2006 by a Female patient taking Brevibloc (View Usage) (Dosage: 120 Mg; Every Day; Iv) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 71 years of age, Patient had the following side effects: blood pressure decreased, cerebral infarction, disturbance in attention, heart rate decreased, iatrogenic injury, procedural complication, vascular injury. During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), MIDAZOLAM HYDROCHLORIDE (View Midazolam Hydrochloride Review and Midazolam Hydrochloride Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), EPHEDRINE HYDROCHLORIDE (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ).

5029094-X | Blood Pressure Decreased, Cerebral Infarction
on Apr 10, 2006 Female patient from JAPAN , 71 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), induction of anaesthesia, maintenance of anaesthesia, hypotonia, blood pressure decreased and was treated with Brevibloc (View Usage). After Brevibloc was administered, patient had the following side effects: blood pressure decreased, cerebral infarction. Brevibloc dosage: . During the same period patient was treated with ATROPINE SULFATE (0.5 Mg For Anaesthetic Premed, Then 1.0 Mg For Side Reaction Prevention Of Antichollnesterase) (View Atropine Sulfate Review and Atropine Sulfate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), EPHEDRINE HYDROCHLORIDE (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ).

5026163-5 | Blood Pressure Decreased, Cerebral Infarction, Disturbance In Attention, Heart Rate Decreased, Post Procedural Complication, Vascular Injury
on May 26, 2006 Female patient from UNITED STATES , 71 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cerebral infarction, disturbance in attention, heart rate decreased, post procedural complication, vascular injury. Brevibloc dosage: 120 Mg;every Day; Iv. During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), EPHEDRINE HYDROCHLORIDE (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ).

5019071-7 | Blood Pressure Decreased, Cerebral Infarction
Patient was taking Brevibloc (View Usage). Patient had the following side effects: blood pressure decreased, cerebral infarction on Apr 10, 2006 from JAPAN Additional patient health information: Female patient , 71 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), induction of anaesthesia, maintenance of anaesthesia, hypotonia, blood pressure decreased and. Brevibloc dosage: . During the same period patient was treated with ATROPINE SULFATE (0.5 Mg For Anaesthetic Premed, Then 1.0 Mg For Side Reaction Prevention Of Antichollnesterase) (View Atropine Sulfate Review and Atropine Sulfate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), EPHEDRINE HYDROCHLORIDE (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ).

4989951-7 | Blood Pressure Decreased, Cerebral Infarction, Heart Rate Decreased, Procedural Complication, Vascular Injury
Adverse event was reported on Apr 17, 2006 by a Female patient taking Brevibloc (View Usage) (Dosage: 120 Mg;every Day;iv) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 71 years of age, After Brevibloc was administered, patient had the following side effects: blood pressure decreased, cerebral infarction, heart rate decreased, procedural complication, vascular injury. During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), EPHEDRINE HYDROCHLORIDE (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ).

4973934-7 | Blood Pressure Decreased, Cerebral Infarction
on Apr 10, 2006 Female patient from JAPAN , 71 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), induction of anaesthesia, maintenance of anaesthesia, hypotonia, blood pressure decreased and was treated with Brevibloc (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cerebral infarction. Brevibloc dosage: . During the same period patient was treated with ATROPINE SULFATE (0.5 Mg For Anaesthetic Premed, Then 1.0 Mg For Side Reaction Prevention Of Antichollnesterase) (View Atropine Sulfate Review and Atropine Sulfate Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), EPHEDRINE HYDROCHLORIDE (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ).

4556392-6 | Skin Necrosis
on Oct 18, 2004 Female patient from , 78 years of age, weighting 156.5 lb, was diagnosed with heart rate increased, hypertension and was treated with Brevibloc (View Usage). Patient had the following side effects: skin necrosis. Brevibloc dosage: 2500 Mg Other Iv.

4546602-3 | Anuria, Cardiac Arrest, Haemodialysis, Overdose
Patient was taking Brevibloc (View Usage). After Brevibloc was administered, patient had the following side effects: anuria, cardiac arrest (What is cardiac arrest?), haemodialysis, overdose on Dec 20, 2004 from Additional patient health information: Female patient , 63 years of age, weighting 242.5 lb, was diagnosed with arrhythmia supraventricular, tachycardia and. Brevibloc dosage: 10 Mg Bolus Iv. During the same period patient was treated with PANTAZOL (PANTOPRAZOLE) (View Pantazol (pantoprazole) Review and Pantazol (pantoprazole) Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), BELOC ZOC MITE (METOPROLOL) (View Beloc Zoc Mite (metoprolol) Review and Beloc Zoc Mite (metoprolol) Label ), DELIX 10 (RAMIPRIL) (View Delix 10 (ramipril) Review and Delix 10 (ramipril) Label ), CLEXANE (ENOXAPARIN NA) (View Clexane (enoxaparin-na) Review and Clexane (enoxaparin-na) Label ), LASIX (View Lasix Review and Lasix Label ), AUGMENTIN (AMOXICILLIN AND CLAVULANIC ACID) (View Augmentin (amoxicillin And Clavulanic Acid) Review and Augmentin (amoxicillin And Clavulanic Acid) Label ).